QS Batterymarch Financial Management’s Achillion Pharmaceuticals ACHN Stock Holding History

QS Batterymarch Financial Management’s Portfolio ACHN Stock Details ACHN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	$1.8M	Buy	+180,076	New	+$1.67M	0.05%	434

Other funds holding ACHN

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

QS Batterymarch Financial Management's ACHN Position: Q3 2014 in Review

QS Batterymarch Financial Management opened a new position in Achillion Pharmaceuticals (ACHN) in Q3 2014: 180,076 shares worth $1.8M. The stake represents 0.05% of the portfolio and ranks #434 among its holdings.

161 funds tracked by Wall St. Rank hold ACHN as of Q3 2014.

QS Batterymarch Financial Management held 180,076 shares of Achillion Pharmaceuticals worth $1.8M as of Q3 2014.
Achillion Pharmaceuticals was a new QS Batterymarch Financial Management position in Q3 2014.
Achillion Pharmaceuticals made up 0.05% of QS Batterymarch Financial Management's portfolio in Q3 2014, its #434 holding.
161 funds tracked by Wall St. Rank held Achillion Pharmaceuticals as of Q3 2014.

Based on QS Batterymarch Financial Management's 13F filing for Q3 2014, filed 14 Nov 2014.